Accord Logo

Intended for UK patients and members of the public

Ibandronic acid 50mg Film-coated Tablets

Ibandronic acid 50mg Film-coated Tablets

PL Number:
0142/0964
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update: To update sections 4.4, 4.5, 4.6, 4.8 and 5.2 of the SmPC in line with the reference product Bondronat 50 mg film-coated tablets (MA number: PLGB 43252/0020; MAH: Atnahs Pharma UK Limited, Dated: 28/03/2024). Consequently, the PIL has been updated. Additionally, editorial and formatting updates have been made to the SmPC and PIL, the PIL has been updated in line with latest QRD template and the tablet description in section 6 of the PIL has been aligned with section 3 of the SmPC.

    Date of approval: 27/06/2025

    PIL sections updated: Heading, Introduction, 2, 3, 4, 5 and 6

  • Description of update: To update sections 4.4, 4.5, 4.6, 4.8 and 5.2 of the SmPC in line with the reference product Bondronat 50 mg film-coated tablets (MA number: PLGB 43252/0020; MAH: Atnahs Pharma UK Limited, Dated: 28/03/2024). Consequently, the PIL has been updated. Additionally, editorial and formatting updates have been made to the SmPC and PIL, the PIL has been updated in line with latest QRD template and the tablet description in section 6 of the PIL has been aligned with section 3 of the SmPC.

    Date of approval: 27/06/2025

    SmPC sections updated: 4.4, 4.5, 4.6, 4.8, 5.2 and 10

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

View product information as a: